P&G Health Q3 Profit Falls 15% Despite 21% Revenue Jump; ₹160 Dividend Declared

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
P&G Health Q3 Profit Falls 15% Despite 21% Revenue Jump; ₹160 Dividend Declared
Overview

Procter & Gamble Health Limited reported a robust Q3 FY26 with revenue climbing 20.7% YoY to ₹373.86 Cr. However, net profit declined 14.6% YoY to ₹77.59 Cr, with EPS falling to ₹46.74. For the nine months ended Dec 31, 2025, revenue grew 14.4% to ₹1037.52 Cr, and net profit surged 22.3% to ₹232.31 Cr, aided by a prior year's exceptional charge. The board declared an interim dividend of ₹160 per share, including a special ₹50 payout.

Procter & Gamble Health Q3 FY26: Revenue Surges, Profit Wobbles Amidst Strong Dividend Payout

Procter & Gamble Health Limited has unveiled its financial results for the third quarter and nine months ended December 31, 2025, revealing a tale of two halves: strong top-line expansion juxtaposed with a profit dip in the latest quarter, offset by substantial shareholder returns.

📉 The Financial Deep Dive

The Numbers:

  • Q3 FY26 Revenue: ₹373.86 Cr, a significant 20.7% year-on-year (YoY) increase from ₹309.77 Cr in Q3 FY25. Quarter-on-quarter (QoQ), revenue also rose 15.1% from ₹324.92 Cr in Q2 FY26.
  • Q3 FY26 Net Profit: ₹77.59 Cr, marking a 14.6% decline YoY from ₹90.90 Cr in Q3 FY25.
  • Q3 FY26 EPS: Basic and Diluted EPS stood at ₹46.74, down 14.6% YoY from ₹54.76.
  • 9M FY26 Revenue: ₹1037.52 Cr, showing a 14.4% YoY growth from ₹907.06 Cr in 9M FY25.
  • 9M FY26 Net Profit: ₹232.31 Cr, a robust 22.3% YoY increase from ₹190.01 Cr in 9M FY25.
  • 9M FY26 EPS: Basic and Diluted EPS rose 22.3% YoY to ₹139.95 from ₹114.47.

The Quality:

The significant revenue growth in Q3 FY26 did not translate into a profit increase, indicating potential margin pressures or increased operating expenses. The reported Net Profit decline of 14.6% YoY for the quarter warrants attention, especially when compared to the strong 20.7% revenue jump. For the nine-month period, the reported profit growth of 22.3% was notably boosted by the absence of an exceptional item of ₹20.19 Cr (asset impairment and Goa plant sale consideration) that impacted 9M FY25 results. Excluding this one-off, the underlying profit trajectory requires closer examination.

The Grill:

(No analyst call transcript was provided with the filing.)

Risks & Outlook:

The divergence between strong revenue growth and declining quarterly profits is a key point of concern for investors, suggesting potential headwinds in cost management or competitive pressures affecting margins. However, the board's decision to declare a substantial interim dividend of ₹160 per equity share, including a special dividend of ₹50, is a strong positive signal to shareholders, indicating confidence in the company's cash generation capabilities despite short-term profit fluctuations. Investors will be keen to understand the sustainability of revenue growth and the drivers behind the Q3 profit compression in future communications.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.